...
首页> 外文期刊>Romanian Journal of Laboratory Medicine >Detection of chromosomal imbalances using combined MLPA kits in patients with syndromic intellectual disability
【24h】

Detection of chromosomal imbalances using combined MLPA kits in patients with syndromic intellectual disability

机译:合并性MLPA试剂盒检测患有综合征性智力障碍的患者的染色体失衡

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Intellectual disability (ID) is a common disorder, with major consequences for individual, family and society. Due to clinical and genetic heterogeneity of ID, in about 50% of cases an etiologic diagnosis cannot be established. The aim of this study was to evaluate the ability of a combination of MLPA kits to establish the diagnosis in 369 patients with syndromic ID and normal or uncertain routine karyotype results. All patients were assessed for chromosome imbalance using SALSA MLPA P064 or P096 kits, if the phenotype was suggestive of a microdeletion syndrome (subgroup A - 186 patients), or subtelomeric P036 and P070 kits, if the phenotype was not suggestive of a microdeletion syndrome or if the result of the standard karyotype was uncertain (subgroup B - 183 patients). Abnormal results detected by these kits were further characterized using appropriate follow-up MLPA kits (Telomere Follow-up set, P029-A1, P250-B2, ME028-B1). In subgroup A we identified 25 patients with microdeletions (13.4%). Using subtelomere screening and follow-up kits in subgroup B we detected cryptic rearrangements in 7.5% cases and identified the origin of the unknown material noticed in the standard karyotype in 10 out of 11 patients. Summarizing data from the two groups, the combined use of MLPA kits led to the diagnosis in 10.6% (38/358) patients with normal karyotype. Using follow-up MLPA kits allowed us both to confirm abnormalities and to determine their size, which facilitated the interpretation of the clinical significance of these rearrangements. For laboratories that do not have yet access to microarray technology, using several MLPA kits represents an effective strategy for establishing the diagnosis in ID patients.
机译:智力障碍(ID)是一种常见的疾病,会对个人,家庭和社会造成重大影响。由于ID的临床和遗传异质性,在大约50%的病例中无法确定病因诊断。这项研究的目的是评估MLPA试剂盒组合对369例具有ID综合征和常规或非常规核型结果的患者进行诊断的能力。如果表型提示存在微缺失综合症,则使用SALSA MLPA P064或P096试剂盒对所有患者进行染色体不平衡评估(A组-186名患者),如果表型提示无微缺失综合症,则使用亚端粒P036和P070试剂盒。如果标准核型的结果不确定(B组-183例患者)。使用适当的随访MLPA试剂盒(Telomere随访套件,P029-A1,P250-B2,ME028-B1)进一步表征这些试剂盒检测到的异常结果。在亚组A中,我们确定了25例微缺失患者(13.4%)。在B组中使用亚端粒筛选和随访试剂盒,我们检测到7.5%病例中的隐匿重排,并确定了11例患者中有10例在标准核型中发现的未知物质的起源。总结两组的数据,结合使用MLPA试剂盒可诊断出10.6%(38/358)核型正常的患者。使用后续的MLPA试剂盒可以使我们既确认异常又确定其大小,从而有助于解释这些重排的临床意义。对于尚未使用微阵列技术的实验室,使用几种MLPA试剂盒可作为在ID患者中建立诊断的有效策略。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号